Cite
HARVARD Citation
Horvath, N. et al. (2019). Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study. Leukemia & lymphoma. 60 (9), pp. 2122-2133. [Online].